Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swissmedic advises caution over choice and use of blood glucose monitors:

This article was originally published in Clinica

Executive Summary

The Swiss medical devices agency, Swissmedic, has issued a warning concerning blood glucose monitors. The notice alerts purchasers and users to the fact that some units, which are to be programmed by the patient, are badly designed in that they can lead the user to inadvertently programme a much higher dose than is correct or safe because of the two different ways of measuring the dose (in litres or decilitres). The Agency notes that the design fault is no longer present in the newer machines coming onto the market and that most manufacturers have been exchanging their systems for units which give a single, straightforward measurement reading. The notice was posted on Swissmedic's website, on September 9.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052890

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel